SCHEMBL6098280

SCHEMBL6098280

CC(CCO)CS(=O)(=O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSIP1 O75475 1/20 0.48
TRPA1 O75762 1/20 0.47
HSD11B1 P28845 6/20 0.43
POLB P06746 1/20 0.42
MMP13 P45452 2/20 0.41
MMP1 P03956 1/20 0.41
ALDH1A1 P00352 2/20 0.41
TP53 P04637 2/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 1/20 0.40
GAA P10253 1/20 0.40
CYP2C19 P33261 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.39
S1PR2 O95136 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7347214 0.85 PSIP1 (0.52) PSIP1TRPA1HSD11B1POLBMMP13
SCHEMBL15214393 0.84 PSIP1 (0.50) PSIP1HSD11B1POLBMMP13MMP1
SCHEMBL20780856 0.84 PSIP1 (0.55) PSIP1HSD11B1POLBMMP13MMP1
SCHEMBL28138744 0.83 HSD11B1 (0.49) PSIP1HSD11B1POLBMMP13MMP1
SCHEMBL5276301 0.81 GAA (0.48) ALDH1A1HTTHSD17B10SMN1; SMN2GAA
SCHEMBL5950906 0.81 GAA (0.48) ALDH1A1HTTHSD17B10SMN1; SMN2GAA
SCHEMBL25015902 0.81 PSIP1 (0.52) PSIP1HSD11B1POLBMMP13MMP1
SCHEMBL7437440 0.81 PSIP1 (0.47) PSIP1HSD11B1POLBMMP13MMP1
SCHEMBL7347205 0.79 PSIP1 (0.54) PSIP1HSD11B1POLBMMP13MMP1
SCHEMBL2444476 0.79 PSIP1 (0.59) PSIP1HSD11B1POLBMMP13MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7101892-B2 Sulfone derivatives as 5-HT7 receptor ligands MERCK SHARP & DOHME LTD. 2006-09-05 US disclosed
US-20040229864-A1 Sulfone derivatives as 5-HT7 receptor ligands MERCK SHARP & DOHME LTD. (GB) 2004-11-18 US disclosed
US-4603208-A MODIFIED POLYISOPRENE CONVERTED TO DOLICHOLS KURARAY CO., LTD. (JP) 1986-07-29 US disclosed
EP-0087638-B1 POLYPRENYL COMPOUNDS AND PREPARATION THEREOF KURARAY CO., LTD. (JP) 1985-06-05 EP disclosed
EP-0087638-A1 Polyprenyl compounds and preparation thereof KURARAY CO., LTD. (JP) 1983-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229864-A1 Sulfone derivatives as 5-HT7 receptor ligands HTR7, HTR2C, HTR1A PSIP1 1776/4885TRPA1 416/4885HSD11B1 767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.